Pitchford is managing director of healthcare investments at Imperial Innovations Group, a UK-listed venture capital firm that primarily supports spin-outs from British universities after its own spin out from Imperial College London.
UK-based biotech company PolyTherics has appointed experienced venture investors Anker Lundemose and Nigel Pitchford to its board. Pitchford is managing director of healthcare investments at Imperial Innovations Group, a UK-listed venture capital firm that primarily supports spin-outs from British universities after its own spin out from Imperial College London. Lundemose is co-founder of several companies…
The rest of this content is only accessible to Global Venturing Subscribers.
This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.
